Skip to main content
. 2013 Aug 29;8(8):e71784. doi: 10.1371/journal.pone.0071784

Figure 2. Pooled Relative Risk for Renal Endpoints in Renin-Angiotensin-Aldosterone-System (RAAS) Trials.

Figure 2